Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
21.49
+0.21 (0.97%)
Mar 27, 2024, 12:00 AM EDT - Market open

CALT Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Year 20222021202020192018
Revenue
802.88229.350.87184.830
Revenue Growth (YoY)
250.07%26141.08%-99.53%--
Cost of Revenue
15.20000
Gross Profit
787.68229.350.87184.830
Selling, General & Admin
774.66390.23141.7262.8831.13
Research & Development
414.75357.49241.37149.8399.26
Other Operating Expenses
20.216.09-2.50.142.09
Operating Expenses
1,210753.8380.59212.85132.48
Operating Income
-421.94-524.46-379.72-28.02-132.48
Interest Expense / Income
-12.539.2556.985.410.01
Other Expense / Income
0-29.58-3.56-0.93-0.44
Pretax Income
-409.42-504.13-433.13-32.5-132.05
Income Tax
2.85-3.840.360.080
Net Income
-412.27-500.29-433.49-32.58-132.05
Shares Outstanding (Basic)
59504646-
Shares Change
18.35%7.88%---
EPS (Basic)
-15.56-19.68-19.32-1.76-10.18
EPS (Diluted)
-15.56-19.68-19.32-1.76-10.18
Free Cash Flow
-311.35-468.18-309.18-71.13-128.19
Free Cash Flow Per Share
-10.54-18.75-13.36-3.07-
Gross Margin
98.11%100.00%100.00%100.00%-
Operating Margin
-52.55%-228.67%-43446.22%-15.16%-
Profit Margin
-51.35%-218.14%-49598.86%-17.63%-
Free Cash Flow Margin
-38.78%-204.13%-35375.40%-38.48%-
EBITDA
-421.94-494.88-376.16-27.09-132.04
EBITDA Margin
-52.55%-215.78%-43038.44%-14.66%-
EBIT
-421.94-494.88-376.16-27.09-132.04
EBIT Margin
-52.55%-215.78%-43038.44%-14.66%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).